Cdc7-IN-7

CAS No. 1402059-17-9

Cdc7-IN-7( —— )

Catalog No. M32832 CAS No. 1402059-17-9

Cdc7-IN-7 is a potent inhibitor of Cdc7 kinase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 178 Get Quote
5MG 255 Get Quote
10MG 374 Get Quote
25MG 606 Get Quote
50MG 864 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cdc7-IN-7
  • Note
    Research use only, not for human use.
  • Brief Description
    Cdc7-IN-7 is a potent inhibitor of Cdc7 kinase.
  • Description
    Cdc7-IN-7 (compound I-E) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-E. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    CDK
  • Recptor
    CDK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1402059-17-9
  • Formula Weight
    410.42
  • Molecular Formula
    C21H22N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OCC1CC1)(=O)C2=C(NN3CCOCC3)OC(=CC=4C=5C(NC4)=NC=CC5)C2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Christian Andrew HASSIG, et al. Methods of treatment of cancer comprising cdc7 inhibitors. WO2019165473A1.
molnova catalog
related products
  • PHA-848125

    A potent, selective, brain penetrant and orally available dual CDK and TRK inhibitor with IC50 of 45 and 53 nM for CDK2/cyclin A and TrkA, respectively; shows cross-reactivity with other CDKs (CDK1/4/5/7), TrkB/C, Kit, Abl and PDGFR (IC50s<1 uM).

  • Cdc7-IN-5

    Cdc7-IN-5 is a potent inhibitor of Cdc7 kinase. Cdc7, a serine-threonine protein kinase enzyme, is essential for the initiation of DNA replication in the cell cycle.

  • 9-Isopropylolomoucin...

    9-Isopropylolomoucine (N9-Isopropylolomoucine), a cell cycle protein-dependent kinase inhibitor, is a thiopurine.